KIF16B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.700000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.346200E-01
Normal-vs-Stage2
7.968200E-01
Normal-vs-Stage3
8.246000E-02
Normal-vs-Stage4
6.324400E-01
Stage1-vs-Stage2
6.603000E-01
Stage1-vs-Stage3
1.559520E-02
Stage1-vs-Stage4
9.800800E-01
Stage2-vs-Stage3
4.548300E-02
Stage2-vs-Stage4
6.997600E-01
Stage3-vs-Stage4
5.969700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.074000E-01
Normal-vs-AfricanAmerican
3.187200E-01
Normal-vs-Asian
9.362000E-01
Caucasian-vs-AfricanAmerican
1.359600E-01
Caucasian-vs-Asian
9.727000E-01
AfricanAmerican-vs-Asian
2.645800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.470200E-01
Normal-vs-Female
9.088800E-01
Male-vs-Female
6.796200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.860800E-01
Normal-vs-Age(41-60Yrs)
5.978800E-01
Normal-vs-Age(61-80Yrs)
9.972200E-01
Normal-vs-Age(81-100Yrs)
8.538000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.589500E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.887700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.128800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.263800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.719800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.208200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.780800E-01
Normal-vs-Daily Drinker
8.261800E-01
Normal-vs-Weekly Drinker
9.134600E-01
Normal-vs-Occasional Drinker
7.881800E-01
Normal-vs-Social Drinker
7.366400E-01
Non Drinker-vs-Daily Drinker
6.447800E-01
Non Drinker-vs-Weekly Drinker
8.761600E-01
Non Drinker-vs-Occasional Drinker
5.723200E-01
Non Drinker-vs-Social Drinker
4.519400E-01
Daily Drinker-vs-Weekly Drinker
8.113000E-01
Daily Drinker-vs-Occasional Drinker
3.709000E-01
Daily Drinker-vs-Social Drinker
2.915200E-01
Weekly Drinker-vs-Occasional Drinker
5.192800E-01
Weekly Drinker-vs-Social Drinker
4.302400E-01
Occasional Drinker-vs-Social Drinker
6.790600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.427400E-01
Normal-vs-Grade 2
8.775700E-02
Normal-vs-Grade 3
1.500620E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.737400E-01
Grade 1-vs-Grade 3
3.695000E-01
Grade 1-vs-Grade 4
2.427400E-01
Grade 2-vs-Grade 3
4.092000E-01
Grade 2-vs-Grade 4
8.775700E-02
Grade 3-vs-Grade 4
1.500620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.394000E-01
Normal-vs-NonDiabetic
9.349600E-01
Diabetic-vs-NonDiabetic
6.235200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.268000E-01
Normal-vs-NoPancreatitis
9.332200E-01
Pancreatitis-vs-NoPancreatitis
3.983400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.603200E-01
Normal-vs-N1
8.191000E-01
N0-vs-N1
5.379600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.784400E-01
Normal-vs-TP53-NonMutant
8.266000E-01
TP53-Mutant-vs-TP53-NonMutant
3.816400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
